Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $267.70 | 12 | 73.7% |
| Education | $95.75 | 2 | 26.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $118.01 | 5 | $0 (2024) |
| ITI, Inc. | $95.75 | 2 | $0 (2023) |
| Lundbeck LLC | $68.39 | 3 | $0 (2024) |
| Alkermes, Inc. | $41.52 | 2 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $39.78 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $106.82 | 5 | Lundbeck LLC ($68.39) |
| 2023 | $72.94 | 2 | ITI, Inc. ($48.84) |
| 2022 | $99.80 | 4 | Neurocrine Biosciences, Inc. ($51.93) |
| 2021 | $83.89 | 3 | ITI, Inc. ($46.91) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.95 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: CNS | ||||||
| 10/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Neuropsychiatry | ||||||
| 07/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.90 | General |
| Category: PSYCHIATRY | ||||||
| 01/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.54 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Neuropsychiatry | ||||||
| 06/14/2023 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $48.84 | General |
| Category: PSYCHIATRY | ||||||
| 09/08/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Neuropsychiatry | ||||||
| 09/02/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 03/25/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Neuropsychiatry | ||||||
| 02/25/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: CNS | ||||||
| 11/11/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: NEUROLOGY | ||||||
| 04/13/2021 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $46.91 | General |
| Category: PSYCHIATRY | ||||||
| 04/01/2021 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: SCHIZOPHRENIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 214 | 875 | $189,064 | $60,845 |
| 2022 | 4 | 194 | 724 | $137,471 | $49,456 |
| 2021 | 3 | 140 | 528 | $98,993 | $33,870 |
| 2020 | 4 | 129 | 311 | $74,430 | $24,226 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 16 | 286 | $69,400 | $26,021 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 320 | $77,920 | $23,184 | 29.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 86 | 252 | $35,794 | $10,185 | 28.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 17 | 17 | $5,950 | $1,455 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 285 | $59,940 | $20,079 | 33.5% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 12 | 163 | $32,505 | $15,797 | 48.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 74 | 248 | $35,226 | $10,191 | 28.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 28 | 28 | $9,800 | $3,389 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 273 | $57,975 | $21,160 | 36.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 53 | 232 | $32,953 | $10,042 | 30.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 23 | 23 | $8,065 | $2,669 | 33.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 46 | 183 | $48,535 | $16,245 | 33.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 31 | 66 | $9,375 | $3,182 | 33.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 38 | $8,115 | $2,574 | 31.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 24 | 24 | $8,405 | $2,225 | 26.5% |
About Christine Mccambridge, PMHNP-BC
Christine Mccambridge, PMHNP-BC is a Psychiatric/Mental Health healthcare provider based in Lincoln City, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1245379650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christine Mccambridge, PMHNP-BC has received a total of $363.45 in payments from pharmaceutical and medical device companies, with $106.82 received in 2024. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($267.70).
As a Medicare-enrolled provider, Mccambridge has provided services to 677 Medicare beneficiaries, totaling 2,438 services with total Medicare billing of $168,396. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Lincoln City, OR
- Active Since 02/05/2007
- Last Updated 09/04/2024
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1245379650
Products in Payments
- INGREZZA (Drug) $118.01
- CAPLYTA (Drug) $95.75
- REXULTI (Drug) $68.39
- HETLIOZ (Drug) $27.40
- ARISTADA (Drug) $21.05
- LYBALVI (Drug) $20.47
- FANAPT (Drug) $12.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.